Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
10x genomics
biotech
2
×
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
abbvie
allergan
amgen
anemia
antibiotic
astellas pharma
astrazeneca
autism
autism spectrum disorder
avexis
becton dickinson
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
cancer
cancer diagnostics
celgene
centers for disease control and prevention
chinook therapeutics
clinical trials
clostridium difficile
community-acquired bacterial pneumonia
dana hilt
daprodustat
What
decisions
2
×
adding
aims
august
bio
biotech
busy
company
days
deal
devices
diagnostic
diagnostics
drugs
expand
fda
fold
help
legacy
make
nanostring
news
nods
opioid
past
physicians
reach
regulatory
roundup
sarepta’s
seven
shkreli’s
slow
stumble
suits
technology
tends
tests
treatment
veracyte
Language
unset
Current search:
decisions
×
biotech
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
